Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma

por Jacob, Anne Sophie, Kaul, Helen, Fuchs, Michael, Gillessen, Sarah, Kreissl, Stefanie, Pluetschow, Annette, Momotow, Jesko, Schaub, Valdete, Huettmann, Andreas, Haenel, Mathias, Zimmermann, Andreas, Dierlamm, Judith, Meissner, Julia, Mathas, Stephan, Martin, Sonja, Engert, Andreas, Hallek, Michael, Borchmann, Peter, Lehmann, Clara
Publicado 2022

T002: Treatment related morbidity in patients with classical Hodgkin Lymphoma: results of the ongoing, randomized phase III HD21 Trial by The German Hodgkin Study Group

por Borchmann, Peter, Moccia, Alden, Greil, Richard, Herzberg, Mark, Fosså, Alexander, Hüttmann, Andreas, Keil, Felix, Dierlamm, Judith, Schaub, Valdete, Hänel, Mathias, Novak, Urban, Meissner, Julia, Hellmuth, Johannes, Mathas, Stephan, Zijlstra, Josée. M., Viardot, Andreas, Hertenstein, Bernd, Martin, Sonja, Giri, Pratush, Kreissl, Stefanie, Fuchs, Michael, Schneider, Gundolf, Rosenwald, Andreas, Klapper, Wolfram, Eich, Hans Theodor, Baues, Christian, Hallek, Michael, Kobe, Carsten, Diehl, Volker, Engert, Andreas
Publicado 2022